Nitrogen dioxide promotes allergic sensitization to inhaled antigen

Journal of Immunology

Volumn 179, Issue 6, 2007, Pages 3680-3688

  Bevelander, Mieke ^a   Mayette, Jana ^a   Whittaker, Laurie A ^a   Paveglio, Sara A ^a   Jones, Christine C ^a   Robbins, Justin ^b   Hemenway, David ^b   Akira, Shizuo ^c   Uematsu, Satoshi ^c   Poynter, Matthew E ^a,d  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b University of Vermont   (United States)

^c OSAKA UNIVERSITY   (Japan)

^d UNIVERSITY OF VERMONT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; ALUMINUM POTASSIUM SULFATE; ANTIGEN; CELL PROTEIN; HEAT SHOCK PROTEIN 70; IMMUNOGLOBULIN E; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; LACTATE DEHYDROGENASE; METHACHOLINE; MYELOID DIFFERENTIATION FACTOR 88; NITROGEN DIOXIDE; OVALBUMIN; TOLL LIKE RECEPTOR 2; IMMUNOLOGIC FACTOR; MYD88 PROTEIN, MOUSE; TLR2 PROTEIN, MOUSE; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; AEROSOL; ALLERGIC ASTHMA; ALLERGIC REACTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATOPY; C57BL 6 MOUSE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME ACTIVITY; EOSINOPHIL; EXPOSURE; FEMALE; HISTOPATHOLOGY; IMMUNE RESPONSE; INHALATION; LUNG FUNCTION; LUNG LAVAGE; METAPLASIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY EPITHELIUM; RESPIRATORY TRACT DISEASE; SENSITIZATION; TH2 CELL; ANIMAL; BRONCHUS HYPERREACTIVITY; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; CYTOLOGY; DRUG EFFECT; EOSINOPHILIA; GENETICS; IMMUNOLOGY; INHALATIONAL DRUG ADMINISTRATION; LUNG; MOUSE MUTANT; MUCUS; PATHOLOGY; PHYSIOLOGY; RESPIRATORY TRACT ALLERGY;

ADMINISTRATION, INHALATION; AEROSOLS; ALLERGENS; ANIMALS; BRONCHIAL HYPERREACTIVITY; EOSINOPHILIA; IMMUNOLOGIC FACTORS; LUNG; METAPLASIA; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUCUS; MYELOID DIFFERENTIATION FACTOR 88; NITROGEN DIOXIDE; OVALBUMIN; RESPIRATORY HYPERSENSITIVITY; TOLL-LIKE RECEPTOR 2;

EID: 35748954362     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.179.6.3680     Document Type: Article

References (53)

1. Shima, M., and M. Adachi. 2000. Effect of outdoor and indoor nitrogen dioxide on respiratory symptoms in schoolchildren. Int. J. Epidemiol. 29: 862-870.
2. 2 on the prevalence of asthma and allergic rhinitis in Italy. Clin. Exp. Allergy 32: 1405-1412.
3. Krishna, M. T., A. J. Chauhan, A. J. Frew, and S. T. Holgate. 1998. Toxicological mechanisms underlying oxidant pollutant-induced airway injury. Rev. Environ. Health 13: 59-71.
4. Gaston, B., J. M. Drazen, J. Loscalzo, and J. S. Stamler. 1994. The biology of nitrogen oxides in the airways. Am. J. Respir. Crit. Care Med. 149: 538-551.
5. McConnell, R., K. Berhane, F. Gilliland, S. J. London, H. Vora, E. Avol, W. J. Gauderman, H. G. Margolis, F. Lurmann, D. C. Thomas, and J. M. Peters. 1999. Air pollution and bronchitic symptoms in Southern California children with asthma. Environ. Health Perspect. 107: 757-760.
6. Neas, L. M., D. W. Dockery, J. H. Ware, J. D. Spengler, F. E. Speizer, and B. G. Ferris. 1991. Association of indoor nitrogen dioxide with respiratory symptoms and pulmonary function in children. Am. J. Epidemiol. 134: 204-219.
7. Strand, V., S. Rak, M. Svartengren, and G. Bylin. 1997. Nitrogen dioxide exposure enhances asthmatic reaction to inhaled allergen in subjects with asthma. Am. J. Respir. Crit. Care Med. 155: 881-887.
8. 2 enhances asthmatic response to a nonsymptomatic allergen dose. Eur. Respir. J. 12: 6-12.
9. Poynter, M. E., R. L. Persinger, C. G. Irvin, K. J. Butnor, H. van Hirtum, W. Blay, N. H. Heintz, J. Robbins, D. Hemenway, D. J. Taatjes, and Y. Janssen-Heininger. 2006. Nitrogen dioxide enhances allergic airway inflammation and hyperresponsiveness in the mouse. Am. J. Physiol. 290: L144-L152.
10. Gilmour, M. I. 1995. Interaction of air pollutants and pulmonary allergic responses in experimental animals. Toxicology 105: 335-342.
11. Lindblad, E. B. 2004. Aluminium compounds for use in vaccines. Immunol. Cell Biol. 82: 497-505.
12. Taube, C., A. Dakhama, and E. W. Gelfand. 2004. Insights into the pathogenesis of asthma utilizing murine models. Int. Arch. Allergy Immunol. 135: 173-186.
13. Kips, J. C., G. P. Anderson, J. J. Fredberg, U. Herz, M. D. Inman, M. Jordana, D. M. Kemeny, J. Lotvall, R. A. Pauwels, C. G. Plopper, et al. 2003. Murine models of asthma. Eur. Respir. J. Suppl. 22: 374-382.
14. Corry, D. B., G. Grunig, H. Hadeiba, V. P. Kurup, M. L. Warnock, D. Sheppard, D. M. Rennick, and R. M. Locksley. 1998. Requirements for allergen-induced airway hyperreactivity in T and B cell-deficient mice. Mol. Med. 4: 344-355.
15. Kawai, T., and S. Akira. 2005. Pathogen recognition with Toll-like receptors. Curr. Opin. Immunol. 17: 338-344.
16. Shi, Y., J. E. Evans, and K. L. Rock. 2003. Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 425: 516-521.
17. Li, M., D. F. Carpio, Y. Zheng, P. Bruzzo, V. Singh, F. Ouaaz, R. M. Medzhitov, and A. A. Beg. 2001. An essential role of the NF-κB/Toll-like receptor pathway in induction of inflammatory and tissue-repair gene expression by necrotic cells. J. Immunol. 166: 7128-7135.
18. Beg, A. A. 2002. Endogenous ligands of Toll-like receptors: implications for regulating inflammatory and immune responses. Trends Immunol. 23: 509-512.
19. Kiura, K., H. Kataoka, M. Yasuda, N. Inoue, and K. Shibata. 2006. The diacylated lipopeptide FSL-1 induces TLR2-mediated Th2 responses. FEMS Immunol. Med. Microbiol. 48: 44-55.
20. Mandron, M., M. F. Aries, R. D. Brehm, H. S. Tranter, K. R. Acharya, M. Charveron, and C. Davrinche. 2006. Human dendritic cells conditioned with Staphylococcus aureus enterotoxin B promote TH2 cell polarization. J. Allergy Clin. Immunol. 117: 1141-1147.
21. Zanin-Zhorov, A., R. Bruck, G. Tal, S. Oren, H. Aeed, R. Hershkoviz, I. R. Cohen, and O. Lider. 2005. Heat shock protein 60 inhibits Th1-mediated hepatitis model via innate regulation of Th1/Th2 transcription factors and cytokines. J. Immunol. 174: 3227-3236.
22. Agrawal, S., A. Agrawal, B. Doughty, A. Gerwitz, J. Blenis, T. Van Dyke, and B. Pulendran. 2003. Cutting edge: different Toll-like receptor agonists instruct dendritic cells to induce distinct Th responses via differential modulation of extracellular signal-regulated kinase-mitogen-activated protein kinase and c-Fos. J. Immunol. 171: 4984-4989.
23. Re, F., and J. L. Strominger. 2001. Toll-like receptor 2 (TLR2) and TLR4 differentially activate human dendritic cells. J. Biol. Chem. 276: 37692-37699.
24. Re, F., and J. L. Strominger. 2004. IL-10 released by concomitant TLR2 stimulation blocks the induction of a subset of Th1 cytokines that are specifically induced by TLR4 or TLR3 in human dendritic cells. J. Immunol. 173: 7548-7555.
25. Yamamoto, K., I. Kawamura, J. Ito, and M. Mitsuyama. 2006. Modification of allergic inflammation in murine model of rhinitis by different bacterial ligands: involvement of mast cells and dendritic cells. Clin. Exp. Allergy 36: 760-769.
26. Chisholm, D., L. Libet, T. Hayashi, and A. A. Horner. 2004. Airway peptidoglycan and immunostimulatory DNA exposures have divergent effects on the development of airway allergen hypersensitivities. J. Allergy Clin. Immunol. 113: 448-454.
27. Redecke, V., H. Hacker, S. K. Datta, A. Fermin, P. M. Pitha, D. H. Broide, and E. Raz. 2004. Cutting edge: activation of Toll-like receptor 2 induces a Th2 immune response and promotes experimental asthma. J. Immunol. 172: 2739-2743.
28. Vabulas, R. M., P. Ahmad-Nejad, S. Ghose, C. J. Kirschning, R. D. Issels, and H. Wagner. 2002. HSP70 as endogenous stimulus of the Toll/interleukin-1 receptor signal pathway. J. Biol. Chem. 277: 15107-15112.
29. Asea, A., M. Rehli, E. Kabingu, J. A. Boch, O. Bare, P. E. Auron, M. A. Stevenson, and S. K. Calderwood. 2002. Novel signal transduction pathway utilized by extracellular HSP70: role of Toll-like receptor (TLR) 2 and TLR4. J. Biol. Chem. 277: 15028-15034.
30. Vabulas, R. M., P. Ahmad-Nejad, C. da Costa, T. Miethke, C. J. Kirschning, H. Hacker, and H. Wagner. 2001. Endocytosed HSP60s use Toll-like receptor 2 (TLR2) and TLR4 to activate the Toll/interleukin-1 receptor signaling pathway in innate immune cells. J. Biol. Chem. 276: 31332-31339.
31. Park, J. S., D. Svetkauskaite, Q. He, J. Y. Kim, D. Strassheim, A. Ishizaka, and E. Abraham. 2004. Involvement of Toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J. Biol. Chem. 279: 7370-7377.
32. Park, J. S., F. Gamboni-Robertson, Q. He, D. Svetkauskaite, J. Y. Kim, D. Strassheim, J. W. Sohn, S. Yamada, I. Maruyama, A. Banerjee, et al. 2006. High mobility group box 1 protein interacts with multiple Toll-like receptors. Am. J. Physiol. 290: C917-C924.
33. Yu, M., H. Wang, A. Ding, D. T. Golenbock, E. Latz, C. J. Czura, M. J. Fenton, K. J. Tracey, and H. Yang. 2006. HMGB1 signals through Toll-like receptor (TLR) 4 and TLR2. Shock 26: 174-179.
34. Scheibner, K. A., M. A. Lutz, S. Boodoo, M. J. Fenton, J. D. Powell, and M. R. Horton. 2006. Hyaluronan fragments act as an endogenous danger signal by engaging TLR2. J. Immunol. 177: 1272-1281.
35. Seong, S. Y., and P. Matzinger. 2004. Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses. Nat. Rev. Immunol. 4: 469-478.
36. Takeda, K., T. Kaisho, and S. Akira. 2003. Toll-like receptors. Annu. Rev. Immunol. 21: 335-376.
37. Kawai, T., and S. Akira. 2006. TLR signaling. Cell Death Differ. 13: 816-825.
38. + T cells expressing membrane-bound TGF-β and FOXP3. J. Clin. Invest. 114: 28-38.
39. Matzinger, P. 2002. The danger model: a renewed sense of self. Science 296: 301-305.
40. Njemini, R., M. Lambert, C. Demanet, and T. Mets. 2003. Elevated serum heatshock protein 70 levels in patients with acute infection: use of an optimized enzyme-linked immunosorbent assay. Scand. J. Immunol. 58: 664-669.
41. Poynter, M. E., R. Cloots, T. van Woerkom, K. J. Butnor, P. Vacek, D. J. Taatjes, C. G. Irvin, and Y. M. Janssen-Heininger. 2004. NF-κB activation in airways modulates allergic inflammation but not hyperresponsiveness. J. Immunol. 173: 7003-7009.
42. Nakanishi, A., S. Morita, H. Iwashita, Y. Sagiya, Y. Ashida, H. Shirafuji, Y. Fujisawa, O. Nishimura, and M. Fujino. 2001. Role of gob-5 in mucus overproduction and airway hyperresponsiveness in asthma. Proc. Natl. Acad. Sci. USA 98: 5175-5180.
43. Allard, J. B., M. E. Poynter, K. A. Marr, L. Cohn, M. Rincon, and L. A. Whittaker. 2006. Aspergillus fumigatus generates an enhanced Th2-biased immune response in mice with defective cystic fibrosis transmembrane conductance regulator. J. Immunol. 177: 5186-5194.
44. Pierre, P., S. J. Turley, E. Gatti, M. Hull, J. Meltzer, A. Mirza, K. Inaba, R. M. Steinman, and I. Mellman. 1997. Developmental regulation of MHC class II transport in mouse dendritic cells. Nature 388: 787-792.
45. Everard, M. L. 2006. The relationship between respiratory syncytial virus infections and the development of wheezing and asthma in children. Curr. Opin. Allergy Clin. Immunol. 6: 56-61.
46. Franze, T., M. G. Weller, R. Niessner, and U. Poschl. 2005. Protein nitration by polluted air. Environ. Sci. Technol. 39: 1673-1678.
47. Franze, T., M. G. Weller, R. Niessner, and U. Poschl. 2003. Enzyme immunoassays for the investigation of protein nitration by air pollutants. Analyst 128: 824-831.
48. Siegel, P. D., N. H. Al-Humadi, E. R. Nelson, D. M. Lewis, and A. F. Hubbs. 1997. Adjuvant effect of respiratory irritation on pulmonary allergic sensitization: time and site dependency. Toxicol. Appl. Pharmacol. 144: 356-362.
49. Pathmanathan, S., M. T. Krishna, A. Blomberg, R. Helleday, F. J. Kelly, T. Sandstrom, S. T. Holgate, S. J. Wilson, and A. J. Frew. 2003. Repeated daily exposure to 2 ppm nitrogen dioxide up-regulates the expression of IL-5, IL-10, IL-13, and ICAM-1 in the bronchial epithelium of healthy human airways. Occup. Environ. Med. 60: 892-896.
50. Han, X., and L. P. Naeher. 2006. A review of traffic-related air pollution exposure assessment studies in the developing world. Environ. Int. 32: 106-120.
51. Holt, P. G., S. Haining, D. J. Nelson, and J. D. Sedgwick. 1994. Origin and steady-state turnover of class II MHC-bearing dendritic cells in the epithelium of the conducting airways. J. Immunol. 153: 256-261.
52. Gong, J. L., K. M. McCarthy, J. Telford, T. Tamatani, M. Miyasaka, and E. E. Schneeberger. 1992. Intraepithelial airway dendritic cells: a distinct subset of pulmonary dendritic cells obtained by microdissection. J. Exp. Med. 175: 797-807.
53. Poynter, M., C. Irvin, and Y. Janssen-Heininger. 2003. A prominent role for airway epithelial NF-κB activation in lipopolysaccharide-induced airway inflammation. J. Immunol. 170: 6257-6265.